All News

Independent pharmacies tap into Medicare Advantage OTC benefits to boost revenue and enhance patient care in a changing health care landscape.

Oral semaglutide (Rybelsus) reduces the risk of major adverse cardiovascular events in adults with high-risk type 2 diabetes, based on data from the SOUL trial.

With constant vaccine and guideline updates reserved for pneumococcal diseases, pharmacists continue to be the authority on pneumococcal vaccine administration.

The ASHP Midyear Meeting 2025 showcases pharmacy's evolution, emphasizing teamwork, specialized roles, and innovative strategies to enhance patient care and outcomes.

For pharmacies, TrumpRx could redefine how prescription drugs are distributed and reimbursed.

The role of community pharmacists is expanding to combat antibiotic resistance and enhance antimicrobial stewardship.

In an exploration of key stakeholders’ perspectives, researchers assess a lifestyle intervention for cardiometabolic health among women during or after pregnancy.

Pharmacists navigate the evolving landscape of cannabis, balancing patient expectations with emerging evidence on cannabidiol and tetrahydrocannabinol for various medical conditions.

In part 3 of our interview with Megan Smith, PharmD, she discusses the common reasons for hesitancy among patients, specifically for the pneumococcal vaccine.

Pharmacists play a crucial role in pain management, offering personalized advice about medications and nonpharmacologic options to enhance patient care.

Laura Mark, PharmD, MHM, FASHP, FABC, and Arpit Mehta, PharmD, MPH, MHA, CPEL, FASHP, discuss the immense role automation has shouldered within pharmacy compounding.

As the pharmacist's scope of practice grows, so does the imperative to prove economic and clinical outcomes to payers, policymakers, and the pharmaceutical industry.

Progress against the opioid crisis shows promise, with overdose deaths declining, and pharmacists play a crucial role in life-saving medication strategies.

Explore the complexities of cannabinoids, focusing on cannabidiol and tetrahydrocannabinol, their effects, side effects, and potential drug interactions in modern use.

Pediatric obesity rates surge, prompting a debate on GLP-1 agonists versus traditional treatments, highlighting efficacy, risks, and long-term implications.

Laura Mark, PharmD, MHM, FASHP, FABC, and Arpit Mehta, PharmD, MPH, MHA, CPEL, FASHP, discuss various roles in centralized IV compounding and robotics.

Megan Smith, PharmD, discusses how pharmacists have taken reigns in boosting pneumococcal vaccine rates across health care.

Pharmacies are evolving into vital health care providers, addressing chronic conditions and mental health while also enhancing patient care through integrated services.

Daniel Cate, PharmD, and his wife, Callie, own a pharmacy in Little Rock, Arkansas, that serves up donuts and prescriptions.

Annie Lambert, PharmD, BCSCP, discusses compliance solutions and the common gaps existing in the pharmacy compounding industry today.

Pharmacists play a vital role in integrating diabetes and depression care, enhancing patient outcomes through screening, individualized treatment, and collaborative approaches.

Lani Bertrand, RPh, discusses Omnicell’s IV compounding solution and how it’s realizing cost savings for pharmacies across the country.

Caitlin Clark shares insights on teamwork and confidence in health care and sports, emphasizing the importance of relationships for success.

This episode explores the risks necessary for successful pharmacy leaders and the inherent nature of pharmacy that makes the profession risk-averse.

Megan Smith, PharmD, breaks down the public health sector’s current understanding and approach toward pneumococcal vaccines.

Community pharmacies redefine patient care by emphasizing personalized services, using innovative models, and addressing social determinants of health for improved outcomes.

Pharmacists enhance asthma care by bridging knowledge gaps, improving medication adherence, and providing cost-effective treatment options for patients.

Exploring the real-time capabilities of chatbots and artificial intelligence (AI), researchers investigate how this technology would impact older adults’ pneumococcal vaccine rates.